By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ZyGem and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) will collaborate to develop sample processing solutions for use in tests for biothreat agents, the Charlottesville, Va.-based company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.